Designing medical technology for resilience: integrating health economics and human factors approaches

Simone Borsci (Corresponding Author), Ijeoma Uchegbu, Peter Buckle, Zhifang Ni, Simon Walne, George B. Hanna

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
1 Downloads (Pure)

Abstract

Introduction: The slow adoption of innovation into healthcare calls into question the manner of evidence generation for medical technology. This paper identifies potential reasons for this including a lack of attention to human factors, poor evaluation of economic benefits, lack of understanding of the existing healthcare system and a failure to recognise the need to generate resilient products. Areas covered: Recognising a cross-disciplinary need to enhance evidence generation early in a technology’s life cycle, the present paper proposes a new approach that integrates human factors and health economic evaluation as part of a wider systems approach to the design of technology. This approach (Human and Economic Resilience Design for Medical Technology or HERD MedTech) supports early stages of product development and is based on the recent experiences of the National Institute for Health Research London Diagnostic Evidence Co-operative in the UK. Expert commentary: HERD MedTech i) proposes a shift from design for usability to design for resilience, ii) aspires to reduce the need for service adaptation to technological constraints iii) ensures value of innovation at the time of product development, and iv) aims to stimulate discussion around the integration of pre- and post-market methods of assessment of medical technology.

Original languageEnglish
Pages (from-to)15-26
Number of pages12
JournalExpert review of medical devices
Volume15
Issue number1
DOIs
Publication statusPublished - 2 Jan 2018
Externally publishedYes

Fingerprint

Human engineering
Economics
Health
Technology
Cost-Benefit Analysis
Product development
Delivery of Health Care
Biomedical Technology Assessment
Innovation
National Institutes of Health (U.S.)
Systems Analysis
Life Cycle Stages
Life cycle
Research

Keywords

  • UT-Hybrid-D
  • Clinical usefulness
  • Health economics
  • Health technology assessment
  • Healthcare technology development
  • Healthcare technology value proposition
  • Human factors
  • Resilience
  • Risks
  • Usability
  • Clinical pathway mapping

Cite this

Borsci, Simone ; Uchegbu, Ijeoma ; Buckle, Peter ; Ni, Zhifang ; Walne, Simon ; Hanna, George B. / Designing medical technology for resilience : integrating health economics and human factors approaches. In: Expert review of medical devices. 2018 ; Vol. 15, No. 1. pp. 15-26.
@article{ed67145dc4a1457fb672986588b78ab9,
title = "Designing medical technology for resilience: integrating health economics and human factors approaches",
abstract = "Introduction: The slow adoption of innovation into healthcare calls into question the manner of evidence generation for medical technology. This paper identifies potential reasons for this including a lack of attention to human factors, poor evaluation of economic benefits, lack of understanding of the existing healthcare system and a failure to recognise the need to generate resilient products. Areas covered: Recognising a cross-disciplinary need to enhance evidence generation early in a technology’s life cycle, the present paper proposes a new approach that integrates human factors and health economic evaluation as part of a wider systems approach to the design of technology. This approach (Human and Economic Resilience Design for Medical Technology or HERD MedTech) supports early stages of product development and is based on the recent experiences of the National Institute for Health Research London Diagnostic Evidence Co-operative in the UK. Expert commentary: HERD MedTech i) proposes a shift from design for usability to design for resilience, ii) aspires to reduce the need for service adaptation to technological constraints iii) ensures value of innovation at the time of product development, and iv) aims to stimulate discussion around the integration of pre- and post-market methods of assessment of medical technology.",
keywords = "UT-Hybrid-D, Clinical usefulness, Health economics, Health technology assessment, Healthcare technology development, Healthcare technology value proposition, Human factors, Resilience, Risks, Usability, Clinical pathway mapping",
author = "Simone Borsci and Ijeoma Uchegbu and Peter Buckle and Zhifang Ni and Simon Walne and Hanna, {George B.}",
note = "Taylor & Francis deal",
year = "2018",
month = "1",
day = "2",
doi = "10.1080/17434440.2018.1418661",
language = "English",
volume = "15",
pages = "15--26",
journal = "Expert review of medical devices",
issn = "1743-4440",
publisher = "Taylor & Francis",
number = "1",

}

Designing medical technology for resilience : integrating health economics and human factors approaches. / Borsci, Simone (Corresponding Author); Uchegbu, Ijeoma; Buckle, Peter; Ni, Zhifang; Walne, Simon; Hanna, George B.

In: Expert review of medical devices, Vol. 15, No. 1, 02.01.2018, p. 15-26.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Designing medical technology for resilience

T2 - integrating health economics and human factors approaches

AU - Borsci, Simone

AU - Uchegbu, Ijeoma

AU - Buckle, Peter

AU - Ni, Zhifang

AU - Walne, Simon

AU - Hanna, George B.

N1 - Taylor & Francis deal

PY - 2018/1/2

Y1 - 2018/1/2

N2 - Introduction: The slow adoption of innovation into healthcare calls into question the manner of evidence generation for medical technology. This paper identifies potential reasons for this including a lack of attention to human factors, poor evaluation of economic benefits, lack of understanding of the existing healthcare system and a failure to recognise the need to generate resilient products. Areas covered: Recognising a cross-disciplinary need to enhance evidence generation early in a technology’s life cycle, the present paper proposes a new approach that integrates human factors and health economic evaluation as part of a wider systems approach to the design of technology. This approach (Human and Economic Resilience Design for Medical Technology or HERD MedTech) supports early stages of product development and is based on the recent experiences of the National Institute for Health Research London Diagnostic Evidence Co-operative in the UK. Expert commentary: HERD MedTech i) proposes a shift from design for usability to design for resilience, ii) aspires to reduce the need for service adaptation to technological constraints iii) ensures value of innovation at the time of product development, and iv) aims to stimulate discussion around the integration of pre- and post-market methods of assessment of medical technology.

AB - Introduction: The slow adoption of innovation into healthcare calls into question the manner of evidence generation for medical technology. This paper identifies potential reasons for this including a lack of attention to human factors, poor evaluation of economic benefits, lack of understanding of the existing healthcare system and a failure to recognise the need to generate resilient products. Areas covered: Recognising a cross-disciplinary need to enhance evidence generation early in a technology’s life cycle, the present paper proposes a new approach that integrates human factors and health economic evaluation as part of a wider systems approach to the design of technology. This approach (Human and Economic Resilience Design for Medical Technology or HERD MedTech) supports early stages of product development and is based on the recent experiences of the National Institute for Health Research London Diagnostic Evidence Co-operative in the UK. Expert commentary: HERD MedTech i) proposes a shift from design for usability to design for resilience, ii) aspires to reduce the need for service adaptation to technological constraints iii) ensures value of innovation at the time of product development, and iv) aims to stimulate discussion around the integration of pre- and post-market methods of assessment of medical technology.

KW - UT-Hybrid-D

KW - Clinical usefulness

KW - Health economics

KW - Health technology assessment

KW - Healthcare technology development

KW - Healthcare technology value proposition

KW - Human factors

KW - Resilience

KW - Risks

KW - Usability

KW - Clinical pathway mapping

UR - http://www.scopus.com/inward/record.url?scp=85038628813&partnerID=8YFLogxK

U2 - 10.1080/17434440.2018.1418661

DO - 10.1080/17434440.2018.1418661

M3 - Article

VL - 15

SP - 15

EP - 26

JO - Expert review of medical devices

JF - Expert review of medical devices

SN - 1743-4440

IS - 1

ER -